Atossa Genetics Inc. announced the appointment of two additional pharmaceutical executives to its strategic advisory board. The board will play a key role in a number of important strategic initiatives in accelerating the clinical development of Atossa’s programs. The company has named former Pfizer executive, Dr. Makarand (Mak) Jawadekar and Dr. Ajit Shetty, Chairman of the Belgium-based Flemish Institute of Biotechnology and former Janssen Pharmaceutica NV executive, to Atossa’s strategic advisory board. Dr. Mak Jawadekar’s professional career at Pfizer Inc. spanned 28 consecutive years, most recently as a Director, Portfolio Management. Dr. Shetty spent his 40-plus year career at Janssen Pharmaceutica NV in Belgium in which he drove the expansion of the Janssen Group of Companies through geographical expansion, new product introduction, and significant market share growth. In his prior capacity as President of Janssen Pharmaceutica USA, Dr. Shetty launched Janssen USA into the larger pharmaceutical market.